1Bauer I, Bauer M, Raddatz A,et al. Influence of gender on stimulated eytokine response in patients with severe sepsis [ J ]. Anaesthesist,2006 Jan 31.
2Kinasewitz GT, Yan SB, Bassen B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism[ J] . Cfit-Care, 2004,8(2):82 -90.
3Li W, Zheng X, Gu J, et al. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin [ J ]. J-Thromb-Haemost, 2005, 3 (7) : 1351 - 1359.
4Fisher C J Jr,Yan SB. Protein C levels as a prognostic indicator of outcome in sepsis and related diseases [ J ]. Crit Care Med, 2000,28(91) :49 - 56.
5Joyce DE,Gelbert L, Ciaecia A, et al. Gene expression profile of antithrombotic protein e defines new mechanisms modulating inflammation and apoptosis[J]. J Biol Chem, 2001, 276(14) : 11199 - 11203.
6Xue M, Thompson P, Kelso I, et al. Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes [ J ]. Exp Cell Res, 2004, 299( 1 ) : 119 - 127.
7Brueckmann M, Horn S, Lang S, et al. Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1 [ J ]. Thromb-Hacmost, 2005, 93 ( 4 ) :743 - 750.
8Manekeller S, Hertfelder H J, von-Spiegel T, et al. Studies on low protein C-expression in severe sepsis [ J ]. Zentralbl-Chir, 2005,130(4) : 362 - 367.
9Lamia B, Anguel N, Richard C, et al. Rapid and beneficial hemodynamie effects of activated protein C in septic shock patients [ J ]. Intensive Care Med, 2005,31 ( 11 ) : 1573 - 1576.
10Nick JA, Coldren CD, Geraci MW, et al. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis [ J ]. Blood, 2004 ,104(13):3878 -3885.
二级参考文献9
1Mesters R , Helterbrand J , Utterback BG , et al. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications [J] . Crit Care Med, 2000,28:2209- 2216.
2Bone RC , Balk RA, Cerra FB, et al . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. The ACCP/SCCM College of Chest Physicians Society of Critical Care Medicine. Chest, 1992, 101:1644-1655.
3Scherer RU, Spangenberg P . Procoagulant activity in patients with isolated head trauma[J] . Crit Care Med , 1998 , 26: 149.
4Lacapra S , Arkel YS , Ku DH. The use of thrombus precursor protein ,D-dimer , prothrombin fragment 1 . 2 , and thrombin antithrombin in the exclusion of proximal deep vein thrombosis and pulmonary embolism[J].Blood Coagul Fibrinolysis , 2000 , 11 : 371-377.
5Paidas MJ , Arkel YS, Ku DH , et al. Markers of the increase in thrombin production in multiple gestion [J]. X Ⅷ ISTH Paris France Abstract, 2001,2262, 2993, 3018.
